Literature DB >> 5815704

Anaphylatoxin release from the third component of human complement by hydroxylamine.

D B Budzko, H Müller-Eberhard.   

Abstract

Treatment of highly purified preparations of the third component of complement (C3) with 0.5M hydroxylamine at 20 degrees C for 15 to 30 minutes, followed by acidification, resulted in dissociation of a peptide from the C3 molecule. The isolated fragment (molecular weight, 7600) resembled enzymatically liberated anaphylatoxin (C3a) with respect to size, charge, amino acid composition, and biological activity. Its capacity to contract smooth muscle was inhibitable by antihistamines; it also produced tachyphylaxis and desensitization of the guinea pig ileum to C3a. Thus native C3 probably contains an esterlike bond and hydroxylamine-liberated anaphylatoxin may represent one of the polypeptide chains of the C3 molecule.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5815704     DOI: 10.1126/science.165.3892.506

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  Cutaneous responses to human C 3 anaphylatoxin in man.

Authors:  K D Wuepper; V A Bokisch; H J Müller-Eberhard; R B Stoughton
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

3.  Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.

Authors:  M C Carroll; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Specific binding of peroxidase-labeled myelin basic protein in allergic encephalomyelitis.

Authors:  A B Johnson; H M Wiśniewski; C S Raine; E H Eylar; R D Terry
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

5.  The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.

Authors:  R E Spitzer; A E Stitzel; V L Pauling; N C Davis; C D West
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.